| Literature DB >> 32268894 |
Zi-Chuan Ding1, Ting-Xian Ling1, Ming-Cheng Yuan1, Yong-Zhi Qin1,2, Ping Mou1, Hao-Yang Wang1, Zong-Ke Zhou3.
Abstract
BACKGROUND: Revision total hip arthroplasty (THA) with severe femoral bone defects remains a major challenge. The purpose of this study is to report the minimum 8-year clinical and radiographic results of revision THA with severe femoral bone defects treated with extensively porous-coated stems and cortical strut allografts.Entities:
Keywords: Cortical strut allografts; Extensively porous-coated stems; Femoral bone defects; Revision THA
Mesh:
Year: 2020 PMID: 32268894 PMCID: PMC7140549 DOI: 10.1186/s12891-020-03250-0
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Demographic data
| Parameters | Numbers |
|---|---|
| No. of patients | 31 |
| Male: female (no. of pts) | 19: 12 |
| Age (years) a | 62 (32) |
| Primary diagnosis (no. of pts., %) | |
| Osteonecrosis of the femoral head | 16 (51.6%) |
| Developmental dysplasia of the hip | 7 (22.6%) |
| Primary osteoarthritis | 5 (16.1%) |
| Femoral neck fractures | 2 (6.5%) |
| Rheumatoid arthritis | 1 (3.2%) |
| Time from primary to revision THA (years) a | 6.4 (7.8) |
| Reason for revision (no. of pts., %) | |
| PFF | 12 (38.7%) |
| AL | 10 (32.3%) |
| PJI | 9 (29.0%) |
| Fixation of previous femoral stems (no. of pts., %) | |
| Cement | 20 (64.5%) |
| Cementless | 11 (35.5%) |
| Degree of femoral bone defects (Paprosky classification) | |
| Type IIIA | 19 (61.3%) |
| Type IIIB | 9 (29.0%) |
| Type IV | 3 (9.7%) |
| ETO utilized | 7 (22.6%) |
| Follow-up (years) b | 11.0 ± 1.5 (range, 8.1–13.5) |
AL Aseptic loosening, PJI Periprosthetic joint infection, PFF Periprosthetic femoral fracture, ETO Extended trochanteric osteotomy
a Skewed distribution data are presented as medians with interquartile ranges
b Normal distribution data are presented as the mean ± standard deviation
Clinical results
| Parameters | Preoperative | Postoperative | |
|---|---|---|---|
| Harris hip score | |||
| Mean in pointsa | 43.4 ± 10.5 | 85.2 ± 6.6 | < 0.001 |
| Rating | < 0.001 | ||
| Excellent (90–100 points) | 0 (0%) | 17 (54.8%) | |
| Good (80–89 points) | 0 (0%) | 11 (35.5%) | |
| Fair (70–79 points) | 1 (3.2%) | 3 (9.7%) | |
| Poor (< 70 points) | 30 (96.8%) | 0 (0%) | |
| WOMACa | |||
| Total | 39.1 ± 17.3 | 75.9 ± 10.4 | < 0.001 |
| Pain | 41.3 ± 18.2 | 82.0 ± 10.8 | < 0.001 |
| Stiffness | 50.5 ± 23.4 | 76.9 ± 16.4 | 0.002 |
| Function | 36.9 ± 17.2 | 75.1 ± 12.9 | < 0.001 |
| SF-12a | |||
| PCS | 30.9 ± 14.7 | 55.9 ± 18.3 | < 0.001 |
| MCS | 34.2 ± 13.7 | 60.0 ± 21.9 | < 0.001 |
| Walking without aids | 0 (0%) | 23 (74.2%) | < 0.001 |
| Thigh pain | – | 3 (9.7%) | |
| Satisfaction | |||
| Very satisfied | – | 23 (74.2%) | |
| Satisfied | – | 5 (16.1%) | |
| Neutral | – | 2 (6.4%) | |
| Dissatisfied | – | 1 (3.2%) | |
| Very dissatisfied | – | 0 (0%) | |
PCS Physical component summary, MCS Mental component summary; The total WOMAC scores, WOMAC pain scores, WOMAC stiffness scores, WOMAC function scores, SF-12 PCS scores and SF-12 MCS scores were normalized to a range of 0 to 100 points, with higher scores presenting better function
a Normal distribution data are presented as the mean ± standard deviation and were analyzed with t test
Radiographic results
| Parameters | Numbers |
|---|---|
| Fixation and stability of stems (no. of pts., %) | |
| Stable bone ingrowth | 28 (90.3%) |
| Stable fibrous ingrowth | 2 (6.4%) |
| Unstable | 1 (3.2%) |
| Incorporation of cortical strut (no. of pts., %) | 31 (100%) |
| Resorption of cortical strut (no. of pts., %) | |
| Mild | 23 (74.2%) |
| Moderate | 8 (25.8%) |
| Severe | 0 (0%) |
| Femoral width (millimeters)a | |
| Pre-op | 31.7 (8.9) |
| IM po-op | 42.4 (12.1) |
| FU | 38.9 (8.2) |
| Changes in femoral width (P Value)** | |
| IM po-op vs Pre-opa | 10.5 ± 0.5 (p < 0.001) |
| FU vs Pre-opa | 7.8 ± 5.6 (p < 0.001) |
| IM po-op vs FUa | 2.5 ± 4.8 ( |
Pre-op Preoperative, IM po-op Immediate postoperative, FU Ten years of follow-up
aSkewed distribution data are presented as medians with interquartile ranges
**The changes in femoral width were calculated by subtracting the latter from the former. The data were normally distributed and are presented as the mean ± standard deviation. P values were analyzed with t tests
Fig. 1a-b Preoperative radiographs of a 38-year-old man who underwent revision THA for periprosthetic joint infection, showing the placement of antibiotic-loaded spacer with Paprosky type IIIA femoral bone defect. c-d Radiograph immediately after revision with extensively porous-coated stem and cortical strut allografts. e-f Radiographs at 9 years after revision. Bone ingrowth and no signs of stem loosening were observed. Cortical strut allografts incorporated to the host bone successfully. Moderate stress shielding was observed in proximal femur both medial and lateral sides (white arrow)
Fig. 2a Preoperative radiographs of a Vancouver-type B3 periprosthetic femoral fracture. b Radiograph at postoperative day 1. Periprosthetic femoral fracture was treated with extensively porous-coated stem and cortical strut allografts. c At 10-year follow-up, no subsidence and radiolucent lines was identified and the stem was considered to be bone ingrowth stable. Bone restoration of bone defect area (white arrow) was observed. Cortical strut allografts incorporated to the host bone successfully and the resorption of cortical strut was assessed as mild
Fig. 3Kaplan-Meier survivorship curve with re-revision for any reason or radiographic signs of loosening as end points
Cementless extensively porous-coated stem with or without cortical strut allografts in revision THA in the literature
| Study | Year | Type of cementless extensively porous-coated stem | Cortical strut allografts usage | Patients (hips) | Mean follow-up (years) | Paprosky classification of bone defects | Incorporation of cortical strut allografts | Clinical results | Radiographic results | Re-revision | Survival |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Paprosky et al. | 1999 | Monoblock: AML and Solution | NA | 170 | 13.2 (range, 10–16) | Type I: 18 Type II: 51 Type IIIa: 82 Type IIIb: 19 | NA | D’Aubigne and Postel scores: 5.4 to 10.8 | Stable bone ingrowth: 139 Stable fibrous ingrowth: 24 Unstable: 7 | 7 for mechanical failure | Greater than 95% at 13.2 years |
| Ng et al. | 2004 | Monoblock: AML and Solution | NA | 23 (24) | 5 (range, 2–10) | NA | NA | HHS: 93.1 (range, 80–100) | Stable bone ingrowth: 20 Stable fibrous ingrowth: 3 Unstable: 1 | 1 for deep infection | NA |
| Hamilton et al. | 2007 | Monoblock: AML, Solution, Prodigy and PFR. | NA | 905 | 5.8 ± 5.5 | NA | NA | NA | NA | 12 for AL 4 for PJI 3 for stem fracture 1 for PFF | 97.5% at 5 years and 95.9% at 10 years |
| Chung et al. | 2012 | Monoblock: AML and Solution | 8 cases (8.3%) | 96 (96) | 5.5 (range, 2.0–11.3) | Type IIIA: 89 Type IIIB: 7 | 8 (100%) | HHS: 92.3 ± 8 (range, 77–100) | Stable bone ingrowth: 92 Stable fibrous ingrowth: 1 | None | 100% at 5.5 years |
| Ahmet et al. | 2018 | Monoblock: Echelon | 13 cases (18.6%) | 66 (70) | 7.8 (range, 3.7–17.2) | Type I: 14 Type II: 27 Type IIIa: 29 | NA | HHS: 72 (range, 43–96) | NA | AL: 1 | 98.4% at both 5 and 10 years |
| Emerson et al. | 1992 | NA | 138 cases (100%) | 107 (114) | 2.1 (range, 0.5–5.5) | NA | 133 (96.4%) | HHS: 79.6 (58 patients only) | Subsidence over 1 cm: 8 | 8 for mechanical failure | NA |
| Pak et al. | 1993 | Monoblock: AML | 95 cases (100%) | 95 | 4.75 (range, 2–8) | NA | 88 (92.6%) | D’Aubigne and Postel scores: 4.2 to 8.7 (union) | NA | AL: 8 | 92.9% at 4.75 years |
| Head et al. | 2000 | NA | 251 cases (100%) | 251 cases | 9.5 (range, 8–12) | NA | 251 (100%) | HHS: average improvement of 45 | NA | 8 cases | NA |
| Barden et al. | 2001 | Monoblock: Solution | 20 cases (100%) | 20 | 4.7 | Nonsupportive diaphysis | 20 (100%) | HHS: 75.7 (range, 57.5–92) | Stable bone ingrowth: 17 Stable fibrous ingrowth: 3 | 3 mechanical failure | NA |
| Mokka et al. | 2013 | Extensively porous-coated stem: 31 Fluted distal fixation stems: 9 | 40 cases (100%) | 40 | 4.3 (range, 1.0–10.4) | Type I: 5 Type II: 8 Type IIIA: 8 Type IIIB: 6 Type IV: 3 | 37 (92.5%) | NA | Stable: 36 Unstable: 4 | 4 for AL | NA |
| Kim et al. | 2015 | Monoblock: Solution | 130 cases (100%) | 120 (130) | 16.1 (range, 12–20) | Type IIIB: 70 Type IV: 60 | 130 (100%) | HHS: 39 ± 10 to 86 ± 14 WOMAC: 62 ± 29 to 22 ± 19 | Stable bone ingrowth: 113 Stable fibrous ingrowth: 5 Unstable: 12 | 10 for AL 2 for PJI | 91% at 16 years |
| Current study | 2019 | Monoblock: Solution | 31 cases (100%) | 31 (31) | 11.0 ± 1.5 (range, 8.1–13.5) | Type IIIA: 18 Type IIIB: 9 Type IV: 4 | 31 (100%) | HHS: 85.2 ± 6.6 WOMAC: 75.9 ± 10.4 SF-12: PCS 55.9 ± 18.3 MCS 60.0 ± 21.9 | Stable bone ingrowth: 28 Stable fibrous ingrowth: 2 Unstable: 1 | 1 for AL | 96.2% at 10 years |
NA Not available